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Strains, culture conditions and protein purification. We used the E. coli K12 
strain MC4100 ([araD139], (argF-lac)169, λ- relA1, rpsL150, rbsR22, flb5301, deoC1, 
pstF25 StrepR), and its derivatives  JGT4 (ClpA−; clpA::kan StrepR); JGT19 (clpP::cat 
StrepR) and JGT20 (dnak756 thr::Tn10, StrepR, TcR). Also, Escherichia coli Origami B 
(BL21, OmpT-, Lon-, TrxB-, Gor-, StrepR, TetR, Novagen) was used as production 
control. K12 strains were transformed with pTrc99a (ApR, IPTG-inducible while 
Origami B was transformed with pET22b, both encoding the protein T22-GFP-H6. All 
strains were cultured in Luria-Bertani (LB) media. [1] Overnight cultures were 
inoculated in shake flasks containing 500 ml of LB with appropriate antibiotics and  
incubated at 37ºC and 250 rpm, growing up to 0.5 and 0.6 OD550 units. The 
expression of T22GFPH6 gene was induced by the addition of 50 µl IPTG at 1 mM 
and cultures were incubated overnight at 20ºC and 250 rpm. Afterwards, cells were 
harvested by centrifugation (3,280 g, 4ºC, 40 min) and pellets were resuspended in 
25 ml of Wash Buffer pH 8.0 (20 mM Tris-HCl, 500 mM NaCl and 20 mM imidazole), 
containing an EDTA-free protease inhibitor cocktail (Complete EDTA-free Roche 
Diagnostics, Indianapolis, USA). Cells were disrupted by pressuring at 1100 psi in a 
French press (Thermo FA-078A) and proteins were purified by His tag-affinity 
chromatography using 1 mL HiTrap Chelating HP column (GE Healthcare, 
Piscataway, NJ) through an AKTA purifier FPLC (GE Healthcare). Separations were 
made by linear gradient of Tris 20 mM, pH 8.0, 500 mM NaCl, and 500 mM imidazole. 
Fractions collected were dialyzed against NaHCO3 160mM pH 7.4 Buffer. Protein 
amounts were determined by Bradford’s assay [2] and analyzed by sodium 
dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) and anti-GFP 
western blot. 
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Fluorescence, size particle and zeta potential. Fluorescence of purified protein 
was measured in a spectrometer Cary Eclipse (Varian, Mulgrave Australia) using 1 
ml cuvettes, at 450 nm of excitation wavelength and 510 nm of emission wavelength. 
The volume and size distribution of nanoparticles in buffer NaHCO3, as well as zeta 
potential, were measured by dynamic light scattering at 633 nm through a Zetasizer 
Nano ZS (Malvern Instruments Limited, Malvern, Worcestershire, UK) using 
disposable plastic cuvettes. Nanoparticles samples were analyzed by triplicate 
averaging fifteen single measurements.  
 
Electron microscopy. Nanoparticles were analysed by transmission electron 
microscopy (TEM) and field emission scanning electron microscopy (FESEM). For 
TEM, protein samples were negatively stained with uranyl acetate by conventional 
methods [3] and observed in a Jeol 1400 microscope operating at 80 kV and 
equipped with a CCD Gatan Erlangshen ES1000W camera. For the quantification of 
nanoparticles size, 185 particles were measured using Gatan Digital Micrograph 
software. For FESEM, protein samples were directly deposited over silicon wafers, 
air dried and observed with an in-lens secondary electron detector through a Zeiss 
Merlin microscope operating at 2kV. For quantification of nanoparticle size 
distribution, a total of 214 nanoparticles were analysed with ImageJ software. 
Statistical differences of quantitative analyses between P1 and P2 were calculated by 
Mann-Whitney tests (U) using SPSS 15.0 software. 
 
Protein internalization in cell culture. Protein internalization was analyzed in sub-
confluent HeLa cell cultures in 12 well-plates (Nunclon™ Delta, Roskilde, Denmark). 
Briefly, medium was removed and cells were washed in PBS. Then 250 µl of 25 nM 
T22-GFP-H6 in OptiPro (Gibco, Paisley, UK), supplemented with L-Glutamine, were 
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added and incubated for 1 h at 37 ºC to allow cell binding and internalization. After 
incubation, trypsin digestion (1 mg/ ml for 15 min), was carried out. Trypsin was 
neutralized by the addition of 2 volumes of regular cell culture medium and samples 
were centrifuged at 1200 rpm for 5 min. Finally, pellets were resuspended in 300 µl of 
PBS and intracellular green fluorescence was analyzed by flow cytometry in a 
FACSCanto system (Becton Dickinson, Franklin Lakes, NJ), using a 15 W air-cooled 
argon-ion laser at 488 nm excitation for GFP. Typically, data were recorded in 
duplicate from 60,000 cell counts. 
 
Modelling. The T22GFPH6 monomer was modelled by homology using Modeler 
9v13 [4] and the following templates: the peptide polyphemusin I structure (pdb code 
1RKK model 1) [5] for T22 (T22-GFP-H6 residues 2 to 19; 74 % identity);  residues 
40 to 49 of the globular domain of Gallus gallus histone H5 (pdb code 1HST) [6] 
(residues 17 to 26; 80 % identity) and the structure with pdb code 1QYO for GFP [7] 
(residues 27 to 262; 98 % identity). The histidine tail was modelled by Modeller’s 
automodel function (residues 263 to 269). 500 models were generated and sorted by 
their DOPE score. [8] Models with “knots” [9] were removed and the one with the best 
per-residue score was selected. 20 models with best DOPE score were analysed 
with the Electrostatic-Desolvation-Profile method, [10] after removal of the N and C 
terminal tails, to predict the binding patch in the T22-GFP-GFP barrel. Residues from 
the patch with a surface accessible area greater than 40 % were used as Ambiguous 
Interaction Restraints (AIR) in HADDOCK. Those in the center of the patch, which 
were also more frequently predicted by EDP (Figure 2E), were selected as active 
residues while the rest were used as passive. 
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To construct the nanoparticle models several runs of HADDOCK were performed, 
enforcing C5 symmetry and using different active and passive residues as AIR. Three 
different combinations where used: T22-tail residues (1 to 25 in the T22-GFP-H6 
monomer) as actives and His-tail residues (262 to 269) as passives; only T22 
residues as actives; T22-tail residues as actives and EDP-predicted residues as 
actives and passives as previously explained. Histidines were protonated according 
to their pKas and pH 7.4 (same used for microscopy sample preparation) using the 
protonate3D [11] function from the MOE package. [12] All generated models where 
clustered as explained in the HADDOCK tutorial [13] and visually inspected with 
Rasmol [14], which was also used for measurements. 3D representations shown in 
figures have been generated with UCSF Chimera. [15] Diameters were calculated 
using the two barrel alpha-carbons farthest apart in the oligomer structure. 
 
Nanoparticle biodistribution in the CXCR4+ tumor model.  CXCR4-
overexpressing SP5 human colorectal cancer line was implanted to generate 
subcutaneous tumors in Swiss nude mice (Charles River, France), as previously 
described. [3] When tumors reached ca. 500 mm3 mice were randomly allocated to 
Origami B, MC4100, JGT4, JGT19, JGT20 or buffer-treated groups (N=3-5/group). 
The study was approved by the Institutional Animal Ethics Committee (protocol Nº 
DAAM: 8339). The experimental mice received a single 500 μg intravenous bolus of 
the corresponding nanoparticles in carbonate pH 7.5 buffer, whereas control mice 
received only buffer. At 5 h post-administration, the fluorescence emitted by the 
nanoparticles accumulated in the whole and slice sectioned tumor and normal tissues 
(kidney, lung, and heart, liver and brain) was measured ex vivo using IVIS® 
Spectrum equipment (Xenogen Biosciences, USA). The fluorescence signal was then 
digitalized, subtracting the autofluorescence, displayed as a pseudocolor overlay and 
     
7 
 
expressed as Radiant efficiency. Data was corrected by the specific fluorescence 
emitted by the different nanoparticles. 
 
Histological and immunohistochemical (IHC) analysis. Tumors were fixed and 
paraffin-embedded, cut into 4 m sections, processed as previously described [3, 16] 
and H&E stained for histological analysis by two independent observers. CXCR4 
membrane expression and nanoparticle cell internalization in tumor and normal 
tissues was assessed by IHC using primary anti-CXCR4 (1:300; Abcam, UK) or anti-
GFP (1:100; Santa Cruz Biotechnology, USA), and secondary HRP conjugated 
antibody, followed by chromogenic detection. [3] The percent of CXCR4-expressing 
cells in relation to the total cell number and their staining intensity was cuantified, 
scoring each from 0 to 3 (where 3 is the maximal intensity) and multiplying both 
values to obtain the H-score. 
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Supplementary Figure 1. Protein purification and preliminary characterization. A) 
Two protein peaks (P1 & P2) were observed in the separation of T22-GFP-H6 
produced in different E. coli strains, by affinity chromatography against an imidazole 
concentration gradient. B) MS spectra of T22-GF-PH6 eluted in P2. Except for 
Origami B, the materials from all strains separated into two major peaks 
corresponding to the molecular weight of the full-length T22-GFP-H6 (30.6 KDa) and 
to a shorter species (~28.5 KDa). C) Circular Dichroism spectra from 260 nm to 205 
nm of T22-GFP-H6 of P2 materials produced in different strains. A peak at 218 nm is 
observed corresponding to beta-sheet secondary structure signal. 
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Supplementary Figure 2.  A) Haematoxylin-eosin stained of SP5 subcutaneous 
colorectal tumors showed a similar architecture and histology among tumors.  B) 
Significant differences in specific fluorescence among nanoparticle variants, as 
measured using the IVIS spectrum equipment.  
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Supplementary Figure 3. 3D representation of the GFP segment of the T22-GFP-
H6 monomer. Backbone coloured in a gradient from blue to red according to the 
number of times (from 0 to 56, respectively) in which a residue is found in an EDP-
predicted binding site. Residues known to affect the fluorescence of the protein are 
shown in ball & stick representation. 
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